NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market on Thursday a 33 percent increase in its fourth quarter revenues that included a 47 percent spike in consumables revenues.

For the three months ended Dec. 31, 2013 the firm recorded $20.9 million in total revenues, up from $15.7 million in Q4 2012. On average, analysts expected revenues of $20.7 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

The New York Times examines ethics and China's push to lead biomedical research.

At her blog, Sally Rockey dives into National Institutes of Health funding data.